GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 1 filers reported holding GENOMIC HEALTH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $405,000 | +13400.0% | 5,970 | +5870.0% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -83.3% | 100 | -83.3% | 0.00% | – |
| Q4 2016 | $18,000 | 0.0% | 600 | -4.9% | 0.00% | – |
| Q3 2016 | $18,000 | +500.0% | 631 | +531.0% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -95.3% | 100 | -92.9% | 0.00% | – |
| Q1 2015 | $43,000 | -4.4% | 1,400 | 0.0% | 0.00% | – |
| Q4 2014 | $45,000 | -4.3% | 1,400 | -15.2% | 0.00% | -100.0% |
| Q3 2014 | $47,000 | +23.7% | 1,650 | +17.9% | 0.00% | – |
| Q2 2014 | $38,000 | +2.7% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q1 2014 | $37,000 | +85.0% | 1,400 | +100.0% | 0.00% | – |
| Q4 2013 | $20,000 | -4.8% | 700 | 0.0% | 0.00% | – |
| Q3 2013 | $21,000 | -4.5% | 700 | 0.0% | 0.00% | -100.0% |
| Q2 2013 | $22,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |